CLONAZEPAM and INSOMNIA

Overview

INSOMNIA is the #10 most commonly reported adverse reaction for CLONAZEPAM, manufactured by H2-Pharma, LLC. There are 7,007 FDA adverse event reports linking CLONAZEPAM to INSOMNIA. This represents approximately 2.0% of all 346,085 adverse event reports for this drug.

Patients taking CLONAZEPAM who experience insomnia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

INSOMNIA is a less commonly reported adverse event for CLONAZEPAM, but still significant enough to appear in the safety profile.

Other Side Effects of CLONAZEPAM

In addition to insomnia, the following adverse reactions have been reported for CLONAZEPAM:

• DRUG INEFFECTIVE — 13,609 reports
• FATIGUE — 10,235 reports
• NAUSEA — 9,563 reports
• ANXIETY — 8,733 reports
• HEADACHE — 8,590 reports
• DEPRESSION — 8,121 reports
• PAIN — 8,031 reports
• OFF LABEL USE — 7,662 reports
• DIZZINESS — 7,243 reports
• DYSPNOEA — 6,832 reports

Other Drugs Associated with INSOMNIA

The following drugs have also been linked to insomnia in FDA adverse event reports:

Does CLONAZEPAM cause INSOMNIA?

INSOMNIA has been reported as an adverse event in 7,007 FDA reports for CLONAZEPAM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is INSOMNIA with CLONAZEPAM?

INSOMNIA accounts for approximately 2.0% of all adverse event reports for CLONAZEPAM, making it a notable side effect.

What should I do if I experience INSOMNIA while taking CLONAZEPAM?

If you experience insomnia while taking CLONAZEPAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages